Transforming growth factor beta
|SRI-011381 is an agonist of TGF-beta signaling pathway, can be used in the treatment of Alzheimer’s disease.
|SRI-011381 HCl is a TGF-beta signaling agonist.
|SJ000291942 is an activator of the canonical bone morphogenetic proteins (BMP) signaling pathway. BMPs are members of the transforming growth factor beta (TGFβ) family of secreted signaling molecules.
|Pirfenidone is an inhibitor for TGF-β production and TGF-β stimulated collagen production, reduces production of TNF-α and IL-1β, and also has anti-fibrotic and anti-inflammatory properties.
|ITD-1 is a selective TGFβ pathway inhibitor with IC50 of 0.85 μM and can act as an inducer of TGFβ type II receptor degradation.
|Disitertide is an inhibitor of TGF-β1.